Eldon C. Mayer III - 01 Mar 2023 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc.

Role
Ex VP & Chief Commerc. Officer
Signature
/s/ Eldon C. Mayer III
Issuer symbol
N/A
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 19:49:56 UTC
Previous filing
30 Jan 2023
Next filing
21 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +98,000 $0.000000 98,000 01 Mar 2023 Common Stock 98,000 $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 . The option vests in 48 equal monthly installments commencing on the grant date of March 1, 2023, subject to the Reporting Person's continuous service as of such date.